ORKA
Oruka Therapeutics, Inc.
$27.96
0.21
(0.76%)
| Exchange: | |
| Market Cap: | 1.047B |
| Shares Outstanding: | 4.71M |
About The Company
| Sector: | Healthcare | |||||
| Industry: | Biotechnology | |||||
| CEO: | Lawrence Otto Klein | |||||
| Full Time Employees: | 28 | |||||
| Address: |
|
|||||
| Website: | http://www.orukatx.com |
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Click to read more…
Revenue Segmentation
EPS
Earnings Call
Income Statement
(* All numbers are in thousands)
Balance Sheet
(* All numbers are in thousands)
Cash Flow Statement
(* All numbers are in thousands)
Analyst Estimates
(* All numbers are in thousands)
